Updated:
ChemRar Ventures
ChemRar Ventures manages early-stage private equity from Moscow.
ChemRar Ventures
ChemRar is a unique group of biotech start up, R&D service and venture investment companies developing and commercializing innovative medicines for treatment of cardiometabolic and infectious diseases, oncology, and CNS pathologies in Russia and abroad.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Russia
City
Moscow
Corporate office
Moscow, Russia
Frequently asked questions
Who runs investment decisions at ChemRar Ventures?
No named principals or decision makers are disclosed in public sources.
Does ChemRar Ventures participate in fund commitments or only direct deals?
Source material provides no information on fund structure or deal format.
What investment stages does ChemRar Ventures typically target?
The firm lists early stage and seed as focus areas.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: